Go to content
UR Home

Pharmacokinetics of torasemide and its metabolites in end-stage renal disease

URN to cite this document:
Krämer, Bernhard K. ; Schwab, A. ; Braun, N. ; Strutz, F. ; Müller, G. A. ; Risler, T.
Date of publication of this fulltext: 08 Sep 2011 06:31


The pharmacokinetics of torasemide, a new loop diuretic, as well as its active metabolites M1 and M3, and its inactive main metabolite, M5, were studied in 12 patients with end-stage renal failure during single i.v. (n = 6) or single oral (n = 6) dosing of 200 mg torasemide, and during chronic oral treatment for 9 days (n = 12). The elimination half-life (t1/2) of torasemide was unchanged in ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons